<p>NEW YORK & PETACH TIKVAH, Israel, Jul 07, 2008 (BUSINESS WIRE) —-BrainStorm Cell Therapeutics Inc. (OTCBB:BCLI), a leading developer of adult stem cell technologies and therapeutics, has completed a preclinical study in collaboration with the W.M. Keck Center for Collaborative Neuroscience at Rutgers, The State University of New Jersey. The study …</p>